Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 6Head & Neck 2Genitourinary 2CNS 2Thoracic 1Other solid neoplasm 1Gynecologic 1Endocrine 1Dermatologic 1Breast 1

Conditions

Carcinoma, Renal Cell 40Kidney Neoplasms 30Melanoma 25Prostatic Neoplasms 24Breast Neoplasms 18Wilms Tumor 16Neoplasm Metastasis 16Ovarian Neoplasms 14Carcinoma, Non-Small-Cell Lung 12Testicular Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Sarcoma 9Pancreatic Neoplasms 9Neuroblastoma 9Testicular Germ Cell Tumor 8Lymphoma, Follicular 8Lymphoma 8Lung Neoplasms 8Hodgkin Disease 8Carcinoma, Hepatocellular 8Triple Negative Breast Neoplasms 7Neoplasms, Plasma Cell 7Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myeloid, Acute 7Leukemia, Lymphocytic, Chronic, B-Cell 7

Interventions

Zoledronic Acid 2Vincristine 2Irinotecan 2Gemcitabine 2Etoposide 2Doxorubicin 2Cyclophosphamide 2saracatinib 1robatumumab 1radium Ra 223 dichloride 1liposomal doxorubicin 1cc-486 1Temozolomide 1Taxes 1Standard of Care 1Radiation 1Quality of Life 1Psychology, Positive 1Practice Guidelines as Topic 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1Methods 1Lomustine 1Injections 1Immunotherapy 1Ifosfamide 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Neoplasms × Cyclophosphamide × Genitourinary × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

NCT00960063 2018-08-27

A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Merck Sharp & Dohme LLC

Phase 1 Terminated
4 enrolled 8 charts
CNSGenitourinarySarcoma

Bone Neoplasms, Carcinoma, Renal Cell, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡